Intuitive Surgical (ISRG)
NASDAQ:ISRG
Want to see ISRG full AI Analyst Report?
Earnings Data
Report Date
Jul 16, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
2.51Last Year’s EPS
2.19Same Quarter Last Year
Moderate Buy
Based on 19 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized strong commercial and financial momentum: double-digit revenue and procedure growth, expanding placements and adoption of new platforms (da Vinci 5, SP, Ion), margin expansion and supportive clinical data. Headwinds were noted but largely manageable in the near term — China and Japan remain challenged, bariatric volume was down due to GLP-1 adoption, there are input-cost and tariff risks, and a contained cybersecurity incident occurred. Overall, positives around growth, profitability, product adoption and clinical validation substantially outweighed the challenges.Company Guidance
Strong Top-Line Growth
Total revenue of $2.77B, up 23% year-over-year (22% constant currency). Recurring revenue grew 23% to $2.4B and represented 86% of total revenue.
Procedure Volume Expansion
Total procedures grew 17% year-over-year. da Vinci procedures grew 16% to 847,000 and Ion procedures grew 39% to 43,000. U.S. procedures increased 15% and outside-U.S. procedures grew 20%.
Product Adoption and System Placements
Placed 431 da Vinci systems in Q1 (up 17% vs prior year), including 232 da Vinci 5 systems, 34 SP systems and 34 XiR systems; placed 52 Ion systems. Installed base and trade-ins supporting upgrades (119 trade-ins vs 67 prior year).
da Vinci 5 and Utilization Gains
da Vinci 5 adoption driving higher utilization: U.S. utilization growth of 4% with da Vinci 5 utilization ~11% higher than Xi. da Vinci 5 installed base nearly 1,500 systems.
Instrument & Service Revenue Strength
Instruments & accessories (I&A) revenue grew 23% to $1.7B. Service revenue rose 19% to $434M; I&A revenue per da Vinci procedure increased to ~$1,880 from $1,780 year-over-year.
Profitability and Margin Expansion
Non-GAAP operating margin at 39%. Non-GAAP gross margin improved to 67.8% from 66.4% a year ago. Non-GAAP net income was $901M (vs $662M prior year); non-GAAP EPS $2.50 vs $1.81.
SP and Ion Momentum
Single-Port (SP) procedures grew 68% year-over-year, with U.S. SP system utilization up 22%. Ion is growing rapidly with procedure growth of 39% and ongoing clinical evidence supporting earlier malignancy identification.
Positive Clinical Evidence
Mayo Clinic study of 2,115 lesions using Ion reported diagnostic yield 79% and malignancy sensitivity 85%, with early-stage primary lung cancer diagnosis increasing 23 percentage points (46% to 69%) from 2019 to 2024 and low complication rates (pneumothorax requiring intervention 1.4%).
ISRG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ISRG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 21, 2026 | $451.29 | $483.62 | +7.16% |
Jan 22, 2026 | $525.81 | $523.99 | -0.35% |
Oct 21, 2025 | $462.74 | $527.03 | +13.89% |
Jul 22, 2025 | $511.00 | $501.95 | -1.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Intuitive Surgical (ISRG) report earnings?
Intuitive Surgical (ISRG) is schdueled to report earning on Jul 16, 2026, After Close (Confirmed).
What is Intuitive Surgical (ISRG) earnings time?
Intuitive Surgical (ISRG) earnings time is at Jul 16, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ISRG EPS forecast?
ISRG EPS forecast for the fiscal quarter 2026 (Q2) is 2.51.
